Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
Kawanaka M, Tomiyama Y, Hyogo H, Koda M, Shima T, Tobita H, Hiramatsu A, Nishino K, Okamoto T, Sato S, Hara Y, Nishina S, Kawamoto H, Chayama K, Okanoue T, Hino K. Kawanaka M, et al. Among authors: shima t. Hepatol Res. 2018 Jun;48(7):521-528. doi: 10.1111/hepr.13054. Epub 2018 Feb 9. Hepatol Res. 2018. PMID: 29316028
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H, Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T; Japan NASH Study Group, Ministry of Health, Labour, and Welfare of Japan. Yasui K, et al. Among authors: shima t. Clin Gastroenterol Hepatol. 2011 May;9(5):428-33; quiz e50. doi: 10.1016/j.cgh.2011.01.023. Epub 2011 Feb 12. Clin Gastroenterol Hepatol. 2011. PMID: 21320639
Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy.
Itoh Y, Nishimura T, Yamaguchi K, Yokomizo C, Fujii H, Minami M, Nagao Y, Sumida Y, Hashimoto H, Umemura A, Shima T, Okanoue T, Yoshikawa T. Itoh Y, et al. Among authors: shima t. Hepatol Res. 2011 Dec;41(12):1145-52. doi: 10.1111/j.1872-034X.2011.00886.x. Epub 2011 Sep 26. Hepatol Res. 2011. PMID: 21951359
[Treatment for chronic hepatitis with normal serum ALT].
Okanoue T, Shima T, Mizuno M. Okanoue T, et al. Among authors: shima t. Nihon Rinsho. 2011 May;69 Suppl 4:156-60. Nihon Rinsho. 2011. PMID: 22096911 Review. Japanese. No abstract available.
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, Murata S, Tohnai I, Sumida Y, Shima T, Kuboniwa M, Umemura K, Kamisaki Y, Amano A, Okanoue T, Ooshima T, Nakajima A. Yoneda M, et al. Among authors: shima t. BMC Gastroenterol. 2012 Feb 16;12:16. doi: 10.1186/1471-230X-12-16. BMC Gastroenterol. 2012. PMID: 22340817 Free PMC article.
Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy.
Nishimura T, Yamaguchi K, Hashimoto H, Niimi T, Yokomizo C, Fujii H, Minami M, Sakamoto M, Ohnish N, Nagao Y, Okita M, Umemura A, Shima T, Okanoue T, Itoh Y. Nishimura T, et al. Among authors: shima t. Hepatol Res. 2012 Oct;42(10):966-73. doi: 10.1111/j.1872-034X.2012.01016.x. Epub 2012 May 1. Hepatol Res. 2012. PMID: 22548706
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.
Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda F, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Kawaguchi T, et al. Among authors: shima t. PLoS One. 2012;7(6):e38322. doi: 10.1371/journal.pone.0038322. Epub 2012 Jun 14. PLoS One. 2012. PMID: 22719876 Free PMC article.
Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus.
Shima T, Uto H, Ueki K, Takamura T, Kohgo Y, Kawata S, Yasui K, Park H, Nakamura N, Nakatou T, Tanaka N, Umemura A, Mizuno M, Tanaka J, Okanoue T. Shima T, et al. J Gastroenterol. 2013 Apr;48(4):515-25. doi: 10.1007/s00535-012-0653-5. Epub 2012 Aug 22. J Gastroenterol. 2013. PMID: 22911170
Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study.
Nishimura T, Yamaguchi K, Fujii H, Okada Y, Yokomizo C, Niimi T, Sumida Y, Yasui K, Mitsuyoshi H, Minami M, Umemura A, Shima T, Okanoue T, Itoh Y. Nishimura T, et al. Among authors: shima t. Hepatol Res. 2013 May;43(5):557-62. doi: 10.1111/j.1872-034X.2012.01091.x. Epub 2012 Sep 14. Hepatol Res. 2013. PMID: 22978477
865 results